Cancer remains one of the most difficult diseases to cure, with many kinds necessitating tailored treatments for effective therapy. Among these types of cancer, the introduction of Imatinib has resulted in substantial advances in treatment for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This groundbreaking medicine has changed cancer treatment by directly targeting the aberrant proteins that allow cancer cells to grow uncontrolled. As a result, Imatinib has...